Mechanism of actions of sumatriptan on coronary flow before and after endothelial dysfunction in guinea-pig isolated heart

British Journal of Pharmacology

Volumn 120, Issue 6, 1997, Pages 1039-1048

  Ellwood, Amanda J ^a   Curtis, Michael J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 HT(1D) receptor; 5 HT2 receptor; Coronary flow; Endothelial ablation; GR127935; Mesulergine; Nitric oxide, sumatriptan

Indexed keywords

ANTIMIGRAINE AGENT; AUTACOID; MESULERGINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; RECEPTOR SUBTYPE; SAPONIN; SEROTONIN 1D ANTAGONIST; SUMATRIPTAN;

ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; GUINEA PIG; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ERGOLINES; GUINEA PIGS; HEART; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXADIAZOLES; PIPERAZINES; SAPONINS; SEROTONIN AGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0030902322     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701009     Document Type: Article

References (58)

1. BAX, W.A., RENZENBRINK, G.J., VAN HEAUVEN-NOLSEN, D., THIJSSEN, E.J.M., BOS, E. & SAXENA, P.R. (1993). 5-HT receptors mediating contractions of the isolated human coronary artery. Eur. J. Pharmacol., 239, 203-210.
2. 1C receptor. J. Pharmacol. Exp. Ther., 264, 709-716.
3. 1-like receptors mediating vasoconstriction and vasodilatation: their characterisation and distribution in the intact canine cardiovascular system. Br. J. Pharmacol., 114, 961-968.
4. 2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation, 87, 874-880.
5. 2 receptors. Life Sci., 32, 2485-2495.
6. 2-receptor agonist. Br. J. Pharmacol., 110, 360-368.
7. 2 receptor activation. Eur. J. Pharmacol., 161, 91-94.
8. DE CATERINA, R., CARPEGGIANI, C. & L'ABBATE, A. (1984). A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Circulation, 69, 889-894.
9. 2B receptors on endothelium-dependent relaxation in rat jugular vein. Br. J. Pharmacol., 114, 400-404.
10. ELLWOOD, A.J. & CURTIS, M.J. (1996a). Mechanism of 5-hydroxytryptamine-induced coronary vasodilatation assessed by direct detection of nitric oxide production in guinea pig isolated heart. Br. J. Pharmacol., 119, 721-729.
11. 1D-like receptor mediated coronary vasoconstriction and mesulergine sensitive, NO-dependent, coronary vasodilation in guinea pig isolated heart. Br. J. Pharmacol., 117, 264P.
12. ELLWOOD, A.J. & CURTIS, M.J. (1996c). The mesulergine-sensitive increase in coronary blood flow evoked by sumatriptan in GR127935-treated guinea-pig isolated hearts is caused by NO released from coronary endothelium. Br. J. Pharmacol., 118, 81P.
13. FELETOU, M., DELLAZUANA, O. & DUHAULT, J. (1994). Serotoninergic receptor subtype in coronary artery smooth muscle from young and atherosclerotic rabbit. J. Pharmacol. Exp. Ther., 268, 124-132.
14. FENUIK, W., HUMPHREY, P.P.A. & PERREN, M.J. (1989). The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetised dogs. Br. J. Pharmacol., 96, 83-90.
15. FREEDMAN, S.B., CHIERCHIA, S., RODRIGUEZ-PLAZA, L., BUGIARDINI, R., SMITH, G. & MASERI, A. (1984). Ergonovine-induced myocardial ischemia: no role for serotoninergic receptors? Circulation, 70, 178-183.
16. FURCHGOTT, R.F. (1983). Role of endothelium in responses of vascular smooth muscle. Circ. Res., 53, 557-573.
17. 1C-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 471-477.
18. 2 and serotonin are possible mediators. Circulation, 79, 154-166.
19. GOLINO, P., PISCIONE, F., WILLERSON, J.T., CAPELLI-BIGAZZI, M., FOCACCIO, A., VILLARI, B., INDOLFI, C., RUSSOLI, E., CONDORELLI, M. & CHIARELLO, M. (1991). Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. New Eng. J. Med., 324, 641-648.
20. 1D subtype. Br. J. Pharmacol., 106, 703-709.
21. HILLIS, D.L. & LANGE, R.A. (1991). Serotonin and acute ischemic heart disease. New Eng. J. Med., 324, 688-689.
22. HOYER, D., CLARKE, D.E., FOZARD, J.R., HATRIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
23. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 1123-1132.
24. HUMPHREY, P.P.A., FENUIK, W., MARRIOTT, A.S., TANNER, R.J.N., JACKSON, M.R. & TUCKER, M.L. (1991). Preclinical studies on the anti-migraine drug, sumatriptan. Eur. Neurol., 31, 282-290.
25. KAUMANN, A.J. & BROWN, A.M. (1990). Human coronary artery spasm induced by 5-hydroxytryptamine: role of receptor subtypes, plaque and stenosis. Naunyn-Schmiedeberg's Arch. Pharmacol., 431, R90, 357 (abstract).
26. KAUMANN, A.J., PARSONS, A.A. & BROWN, A.M. (1993). Human arterial constrictor serotonin receptors. Cardiovasc. Res., 27, 2094-2103.
27. KELM, M. & SCHRADER, J. (1990). Control of coronary vascular tone by nitric oxide. Circ. Res., 66, 1561-1575.
28. LAMPING, K.G., KANATSUKA, H., EASTMAN, C.L., CHILIAN, W.M. & MARCUS, M.L. (1989). Nonuniform vasomotor responses of coronary microcirculation to serotonin and vasopressin. Circ. Res., 65, 343-351.
29. LEFF, P., MARTIN, G.R. & MORSE, J.M. (1987). Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by the use of tryptamine analogues. Br. J. Pharmacol., 91, 321-331.
30. 1-receptor agonist on central haemodynamics and coronary circulation. Br. J. Clin. Pharmacol., 34, 541-546.
31. 1-receptor agonist, on systemic, pulmonary and coronary circulation. Circulation, 87, 401-405.
32. MARTIN, G.R., BROWNING, C. & GILES, H. (1993). Further characterisation of an atypical 5-HT receptor mediating endothelium-dependent relaxation. Br. J. Pharmacol., 110, 137P.
33. MCFADDEN, E.P., BAUTERS, C., LABLANCHE, J.M., LEROY, F., CLARKE, J.G., HENRY, M., SCHANDRIN, S., DAVIES, G.J., MASERI, A. & BERTRAND, M.E. (1992). Effect of ketanserin on proximal and distal coronary constrictor responses to intracoronary infusion of serotonin in patients with stable angina, patients with variant angina, and control patients. Circulation, 86, 187-195.
34. MCFADDEN, E.P., CLARKE, J.G., DAVIES, G.J., KASKI, J.C., HAIDER, A.M. & MASERI, A. (1991). Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. New Eng. J. Med., 324, 648-654.
35. MENON, M.K., WOLF, A., ZEHETGRUBER, M. & BING, R.J. (1989). An improved chemiluminescence assay suggests non nitric oxide-mediated action of lysophosphatidylcholine and acetylcholine. Proc. Soc. Exp. Med. Biol., 191, 316-319.
36. NOBLE, M.I. & DRAKE-HOLLAND, A.J. (1990). Evidence for a role of serotonin in the initiation of coronary artery thrombosis in the dog and man. Clin. Physiol. Biochem., 8 (Supp 3), 50-55.
37. OTTERVANGER, J.P., PAALMAN, H.J.A., BOXMA, G.L. & STRICKER, B.H.C. (1993). Transmural myocardial infarction with sumatriptan. Lancet, 341, 861-862.
38. PABLA, R. & CURTIS, M.J. (1995). Effects of nitric oxide modulation on cardiac arrhythmias in the rat isolated heart. Circ. Res., 77, 984-992.
39. PARK, K.H., RUBBIN, L.E., GROSS, S.S. & LEVI, R. (1992). Nitric oxide is a mediator of hypoxic coronary vasodilatation. Circ. Res., 71, 992-1001.
40. 1-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 592-596.
41. 1Dβ receptor gene. Biochem. Pharmacol., 50, 1651-1658.
42. 1B receptors. Eur. J. Pharmacol. Mol. Pharmacol., 290, 95-103.
43. 1Dβ receptors mediating inhibition of cAMP in permanently transfected CHO-KI cells: pharmacological agonists and antagonists. Cell Pharmacol., 2, 49-57.
44. PAZOS, A., HOYER, D. & PALACIOS, J.M. (1985). Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. Eur. J. Pharmacol., 106, 531-538.
45. 1D binding sites. Eur. J. Pharmacol., 163, 133-136.
46. REES, S.A. & CURTIS, M.J. (1993). Selective IK blockade as an anti-arrhythmic mechanism in ischaemic heart disease. Effects of UK 66-914 in the rat and rabbit. Br. J. Pharmacol., 108, 139-145.
47. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery. Br. J. Pharmacol., 102, 386-390.
48. SAXENA, P.R. & VILLALON, C.M. (1990). Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol., 15, (Supp 7), S17-S34.
49. 1D receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 135-138.
50. 1D receptor subtype. J. Pharmacol. Exp. Ther., 252, 387-395.
51. SCHOEFFTER, P. & SAHIN-ERDEMLI, I. (1992). Further characterisation of the 5-hydroxytryptamine 5-HT1-like receptor mediating contraction of guinea-pig iliac artery. Eur. J. Pharmacol., 219, 295-301.
52. 1D receptor antagonist. Br. J. Pharmacol., 112, 9P.
53. 1D receptor antagonist. Behav. Brain. Res., 73, 157-161.
54. TODA, N. & OKOMURA, T. (1990). Comparison of response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries. J. Pharmacol. Exp. Ther., 253, 676-682.
55. VAN DEN BERG, E.K., SCHMITZ, J.M., BENEDICT, C.R., MALLOY, C.R., WILLERSON, J.T. & DEHMER, G.J. (1989). Transcardiac serotonin concentration is increasing in selective patients with limiting angina and complex coronary morphology. Circulation, 79, 116-124.
56. 1Dβ receptors. Br. J. Pharmacol., 114, 363P.
57. WIEST, E., TRACH, V. & DAMMGEN, J. (1989). Removal of endothelial function in coronary resistance vessels by saponin. Basic Res. Cardiol., 84, 469-478.
58. WILLETT, F., CURZEN, N., ADAMS, J. & ARMITAGE, M. (1992). Coronary vasospasm induced by subcutaneous sumatriptan. Br. Med. J., 304, 1145.